Spruce Biosciences, Inc.
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.74 | 4.11 | 5.81 | 5.41 | 3.75 | 3.01 | 1.12 | 1.24 | 1.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | – | – | – | – | – | 0.15 | 0.16 | 0.16 | 0.14 | 0.17 | 14.83 | 0.17 | 14.43 | 28.24 | 24.90 | 0.03 | 0.03 | 0.03 | 15.12 | – | – | – | – | – | 0.01 | – | – | – | |
| – | – | – | – | – | – | – | – | -0.15 | -0.16 | -0.16 | -0.14 | -0.17 | -14.83 | -0.17 | -14.43 | -23.51 | -20.79 | 5.81 | 5.38 | 3.75 | 3.01 | 1.12 | – | 1.22 | – | – | -0.01 | – | – | – | |
| 147.47 | 147.47 | 3.49 | 4.81 | 7.62 | 10.24 | 12.87 | 9.62 | 11.09 | 15.03 | 14.17 | 10.26 | 13.93 | 14.83 | 14.35 | 14.43 | 28.24 | 24.90 | 25.50 | 20.81 | 19.31 | 15.12 | 12.21 | 38.11 | 18.97 | 0.71 | 8.90 | 5.35 | 5.52 | 5.00 | 11.87 | |
| 38.92 | 38.92 | 0.76 | 0.48 | 0.86 | 1.31 | 2.97 | 4.17 | 5.13 | 4.28 | 4.60 | 4.72 | 5.28 | 4.62 | 4.52 | 5.34 | 8.32 | 5.71 | 6.12 | 5.53 | 8.08 | 6.65 | 6.44 | 5.89 | 6.40 | 5.15 | 5.72 | 9.13 | 3.22 | 1.79 | 7.81 | |
| 185.03 | 185.03 | 4.25 | 5.30 | 8.49 | 11.56 | 15.84 | 13.80 | 16.22 | 19.31 | 18.76 | 14.98 | 19.21 | 19.45 | 18.87 | 5.34 | 8.32 | 5.71 | 31.61 | 26.31 | 27.39 | 21.76 | 18.64 | 43.99 | 25.37 | 4.44 | 14.61 | 14.48 | 8.74 | 6.79 | 19.67 | |
| -186.39 | -186.39 | -4.25 | -5.30 | -8.49 | -11.56 | -15.84 | -13.80 | -16.22 | -19.31 | -18.76 | -14.98 | -19.21 | -19.45 | -18.87 | -19.77 | -31.83 | -26.51 | -25.81 | -20.93 | -23.65 | -18.75 | -17.52 | -42.75 | -25.37 | -4.44 | -14.61 | -14.48 | -8.74 | -6.79 | -19.67 | |
| – | – | 0.01 | 0.10 | 0.12 | 0.17 | 0.13 | 0.13 | 0.15 | 0.13 | 0.14 | 0.14 | 0.14 | 0.15 | 0.18 | 0.21 | 0.32 | 0.24 | 0.22 | 0.20 | 0.18 | 0.16 | 0.13 | 0.10 | 0.06 | 0.05 | 0.03 | 0.01 | 0.49 | 0.45 | 0.74 | |
| -185.03 | -185.03 | -4.23 | -5.38 | -8.55 | -11.66 | -15.88 | -13.80 | -16.33 | -19.41 | -18.84 | -15.06 | -19.26 | -19.44 | -18.61 | -18.19 | -30.84 | -24.33 | -23.34 | -18.65 | -21.76 | -17.16 | -16.15 | -41.84 | -24.58 | -3.41 | -14.58 | -19.11 | -8.94 | -6.68 | -21.12 | |
| – | – | 0.04 | 0.12 | 0.19 | 0.23 | 0.22 | 0.24 | 0.18 | 0.16 | 0.21 | 0.18 | 0.05 | 0.32 | -0.25 | -1.55 | -0.67 | 2.38 | -0.03 | -1.81 | -0.05 | – | – | – | – | – | – | – | – | – | – | |
| -185.03 | -185.03 | -4.23 | -5.38 | -8.55 | -11.66 | -15.88 | -13.80 | -16.33 | -19.41 | -18.84 | -15.06 | -19.26 | -19.44 | -18.61 | -18.19 | -30.84 | -24.33 | -23.34 | -18.65 | -21.76 | -17.16 | -16.15 | -41.84 | -24.58 | -3.41 | -14.58 | -19.11 | -8.94 | -6.68 | -21.12 | |
| -186.37 | -186.37 | -4.21 | -5.28 | -8.42 | -11.46 | -15.74 | -13.66 | -16.16 | -19.25 | -18.67 | -14.88 | -19.08 | -19.27 | -18.39 | -17.94 | -30.48 | -24.05 | -23.09 | -18.43 | -21.55 | -16.98 | -16.00 | – | -24.50 | -3.35 | -14.55 | -19.09 | -8.26 | -5.96 | -20.02 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.